Devora Delman

808 total citations
8 papers, 188 citations indexed

About

Devora Delman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Devora Delman has authored 8 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Devora Delman's work include Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Immune cells in cancer (3 papers). Devora Delman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Immune cells in cancer (3 papers). Devora Delman collaborates with scholars based in United States. Devora Delman's co-authors include Gregory L. Beatty, Peter Peterson, James M. Bogenberger, Bruce F. Kimler, Steven Weitman, Clifford J. Whatcott, Keith Stewart, Chang-Xin Shi, Meredith L. Stone and Steven L. Warner and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Nature Immunology.

In The Last Decade

Devora Delman

8 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devora Delman United States 6 91 72 51 44 23 8 188
Rachael B. Rowswell-Turner United States 9 47 0.5× 69 1.0× 7 0.1× 114 2.6× 34 1.5× 15 217
Minfang Song China 6 101 1.1× 49 0.7× 8 0.2× 43 1.0× 62 2.7× 12 180
Dzana Dervovic Canada 9 87 1.0× 112 1.6× 29 0.6× 129 2.9× 16 0.7× 12 251
Omar Saavedra Spain 9 86 0.9× 66 0.9× 30 0.6× 36 0.8× 14 0.6× 22 167
Lynn McCallum United Kingdom 9 208 2.3× 35 0.5× 56 1.1× 49 1.1× 35 1.5× 14 289
Stefanie Kreutmair Germany 9 88 1.0× 49 0.7× 53 1.0× 40 0.9× 9 0.4× 21 173
Tsun Ki Jerrick To United States 3 99 1.1× 81 1.1× 12 0.2× 143 3.3× 47 2.0× 4 241
John Seavitt United States 2 64 0.7× 49 0.7× 27 0.5× 158 3.6× 15 0.7× 2 224
Jorge Vaz Pinto Neto Brazil 4 107 1.2× 50 0.7× 39 0.8× 19 0.4× 16 0.7× 6 182

Countries citing papers authored by Devora Delman

Since Specialization
Citations

This map shows the geographic impact of Devora Delman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devora Delman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devora Delman more than expected).

Fields of papers citing papers by Devora Delman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devora Delman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devora Delman. The network helps show where Devora Delman may publish in the future.

Co-authorship network of co-authors of Devora Delman

This figure shows the co-authorship network connecting the top 25 collaborators of Devora Delman. A scholar is included among the top collaborators of Devora Delman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devora Delman. Devora Delman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Li, Yan, Meredith L. Stone, Devora Delman, et al.. (2024). Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. Cell Reports Medicine. 5(2). 101397–101397. 17 indexed citations
2.
Stone, Meredith L., Jesse Lee, Jae W. Lee, et al.. (2024). Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins. Nature Immunology. 25(5). 755–763. 23 indexed citations
3.
Stone, Meredith L., Yan Li, Kathleen Graham, et al.. (2024). Abstract C029: Multiple non-redundant immune checkpoints direct therapeutic resistance to chemotherapy and anti-CSF1R in pancreatic ductal adenocarcinoma. Cancer Research. 84(2_Supplement). C029–C029. 1 indexed citations
4.
Thomas, Stacy K., Max M. Wattenberg, Mark Uhlik, et al.. (2023). Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. Nature Communications. 14(1). 6330–6330. 20 indexed citations
5.
Sohal, Davendra, Mai T. Duong, Devora Delman, et al.. (2021). Immunologic predictors of therapeutic response to neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma (PDA) in SWOG S1505.. Journal of Clinical Oncology. 39(3_suppl). 419–419. 1 indexed citations
6.
Bahary, Nathan, Andrea Wang‐Gillam, Sigurdís Haraldsdóttir, et al.. (2018). Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.. Journal of Clinical Oncology. 36(15_suppl). 4015–4015. 35 indexed citations
7.
Bogenberger, James M., Clifford J. Whatcott, Devora Delman, et al.. (2017). Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget. 8(63). 107206–107222. 72 indexed citations
8.
Delman, Devora, Carol J. Fabian, Bruce F. Kimler, Hung‐Wen Yeh, & Brian K. Petroff. (2015). Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development. Nutrition and Cancer. 67(5). 857–864. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026